Afatinib monotherapy in EGFR-mutant lung adenocarcinoma.
Judith A
JA
Gilbert
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000235:genetics; D000077716:Afatinib; D017326:Clinical Trials, Phase III as Topic; D066246:ErbB Receptors / Q000235:genetics*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation / Q000235:genetics*; D011799:Quinazolines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D011799:Quinazolines; D000077716:Afatinib; C512478:EGFR protein, human; D066246:ErbB Receptors